AllAnalyst Report
logoMorningstarSeptember 15, 2020

Zoetis Inc.: Zoetis Sees That Even COVID-19 Can't Stand Between Owners and Their Pets; Raising Our FVE

Symbols
ZTS
Sector(s)
Healthcare
Rating
Premium
Current Price
$163.49
Fair Value
Premium
Economic Moat
Premium
Stewardship
Premium
Summary

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly half of total revenue from production animals (cattle, pigs, poultry, and so on), and companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE